在儿科移植患者中,基于模型的mycophenolic acid剂量优化
Astrid Heida1, Nynke G L Jager2, Rob E Aarnoutse2
1Department of Pharmacy, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Astrid.Heida@radboudumc.nl.
European journal of clinical pharmacology
|August 17, 2024
概括
在儿科移植患者中,一种新的mycophenolic acid (MPA) 药理动力学模型改善了初始剂量. 这种优化的治疗方案增加了在治疗早期实现治疗目标的可能性,以获得更好的结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 儿科医学 儿科医学
背景情况:
- 菌酸 (MPA) 对于预防儿科移植接受者的排斥至关重要.
- 优化MPA剂量对于最大限度地提高疗效和最大限度地降低毒性至关重要.
- 种群药动力学 (PK) 建模为剂量个性化提供了一个框架.
研究的目的:
- 开发和验证儿童移植患者中MPA的人口PK模型.
- 使用该模型优化初始MPA剂量方案.
- 改善在这个脆弱的患者群体中早期治疗目标的实现.
主要方法:
- 分析了荷兰一家学术医院的儿科移植接受者的数据.
- 使用NONMEM开发了一种具有Erlang类型吸收的双隔间PK模型.
- 该模型得到了外部验证,并用于创建一个优化的剂量方案.
主要成果:
- 一个群体PK模型准确地描述了30名儿科患者的MPA度.
- 与许可剂量相比,优化的初始剂量方案将预测的目标AUC从35%提高到42%.
- 该模型在外部验证数据集中显示出足够的性能.
结论:
- 在儿科移植患者中成功开发了一种MPA的强大的人口PK模型.
- 预计优化剂量方案将提高早期治疗的疗效.
- 该模型支持个性化的MPA剂量策略,特别是与治疗药物监测相结合时.
相关概念视频
Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
Pharmacokinetic Models: Overview
627
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
627
Nonlinear Pharmacokinetics: Overview
317
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
317
Pharmacokinetic Models: Comparison and Selection Criterion
50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
196
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
196
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241


